Boston-based venture capital firm SV Life Sciences is working on its sixth fund, with a fundraising target of $400 million, according to a Form D filing on the U.S. Securities and Exchange ...
SV Life Sciences has bought a majority stake in Ximedica. No financial terms were disclosed. As a result of the transaction, Randall S. Barko, president and CEO of Ximedica and the company’s current ...
today announced the successful completion of a $10 million Series A round led by top-tier life sciences venture investors and . The company is launching out of , a premier medical device incubator ...
For the details of SV Life Sciences Advisers, LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=SV+Life+Sciences+Advisers%2C+LLC SV ...
Robert Palmisano has joined SV Life Sciences as a venture partner. He most recently served as CEO of IntraLase, which was acquired by Advanced Medical Optics earlier this year for over $800 million.
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The venture capital firm, now called SV Health Investors ...
Boston life sciences-based venture capital firm SV Life Sciences has appointed Paul Wallace as a venture partner on the health-care services team. Boston life sciences-based venture capital firm SV ...
SV Life Sciences Raises Over US $570 Million for Fourth Fund, SV Life Sciences Fund IV BOSTON & SAN FRANCISCO & LONDON--Feb 20, 2007 - SV Life Sciences (SVLS), formerly Schroder Ventures Life Sciences ...
Add Yahoo as a preferred source to see more of our stories on Google. LONDON (Reuters) - The world's first fund focused on preventing and treating dementia was launched on Wednesday, backed by leading ...
today announced the successful completion of a $10 million Series A round led by top-tier life sciences venture investors and . The company is launching out of , a premier medical device incubator ...
NEW YORK--(BUSINESS WIRE)--Cibiem, Inc. today announced the successful completion of a $10 million Series A round led by top-tier life sciences venture investors SV Life Sciences and Third Rock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results